EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Absence of Clinically Meaningful Drug-Drug Interactions with Rezafungin: Outcome of Investigations

Shawn Flanagan, Helen Walker, Voon Ong iD, Taylor Sandison

Microbiology Spectrum · 15.06.2023 · 11 (3)

DOI: 10.1128/spectrum.01339-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 15.06.2023. Verfasst von Shawn Flanagan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cidara Therapeutics, Inc., San Diego, California, USA. Hauptthemen laut MEDLINE: Candidiasis, Echinocandins. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cidara Therapeutics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antifungal agents used to treat life-threatening infections are often associated with severe drug-drug interactions (DDIs) that may limit their usefulness. Rezafungin, a newly approved once-weekly echinocandin, has been shown to be free of DDIs based on extensive nonclinical and clinical testing described in this study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CandidiasisEchinocandinsHumansAntifungal AgentsCandidaDrug InteractionsClinical Trials, Phase I as TopicCross-Over Studies

Stichwörter der Autor:innen

cytochrome P450drug transportersdrug-drug interactionsechinocandinspharmacokinetic profilerezafungin

Substanzen

Antifungal AgentsEchinocandins

Autor:innen und Institutionen

  • Cidara Therapeutics, Inc., San Diego, California, USA.
  • Mundipharma Ltd., Cambridge, United Kingdom.

ORCID-Profile: Voon Ong

Förderung

  • Cidara Therapeutics

Zitieren

APA

Flanagan, S., Walker, H., Ong, V., & Sandison, T. (2023). Absence of Clinically Meaningful Drug-Drug Interactions with Rezafungin: Outcome of Investigations. Microbiology Spectrum, 11(3). https://doi.org/10.1128/spectrum.01339-23

Vancouver

Flanagan S, Walker H, Ong V, Sandison T. Absence of Clinically Meaningful Drug-Drug Interactions with Rezafungin: Outcome of Investigations. Microbiology Spectrum. 2023;11(3). doi:10.1128/spectrum.01339-23

BibTeX
@article{Flanagan2023,
  author = {Flanagan, Shawn and Walker, Helen and Ong, Voon and Sandison, Taylor},
  title = {Absence of Clinically Meaningful Drug-Drug Interactions with Rezafungin: Outcome of Investigations},
  journal = {Microbiology Spectrum},
  year = {2023},
  volume = {11},
  number = {3},
  doi = {10.1128/spectrum.01339-23}
}
Kostenlos starten →